With an emerging interest in the role of the <i>APOE</i> genotype in mediating metformin's effects on cognitive decline in AD patients, we sought to investigate whether metformin usage is associated with a reduced risk of severe dementia. This evidence concerns the gene APOE and Alzheimer disease.